Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02110134 · ClinicalTrials.gov registry record · NA
A Study of the RevLite Laser System for the Treatment of Refractory Mixed Type Melasma
A NA study of Melasma, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT02110134: Completed NA study of Melasma, sponsored by Cynosure.
NCT02110134 is a NA study of Melasma that has completed, run by Cynosure. The registered enrollment target is 6 participants, below the 44-participant average among 8 other Melasma trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02110134, a NA study of Melasma, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare a hydroquinone skin care regimen alone to a combination of Revlite Laser treatment with a hydroquinone skin care regimen for the treatment of melasma.
Primary Outcome
Adverse events were collected and reported to test the safety and efficacy of the device.
Conditions Studied
Interventions
- DEVICE Revlite Laser System with hydroquinone skin care regimen
- OTHER Hydroquinone skin care regimen
Study Locations (1)
New York
- NY Laser and Skin Care - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-05 |
| Phase | NA |
What the finished NCT02110134 record still lists
NCT02110134 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 44-participant average among 8 other Melasma trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Melasma appearing as the primary indexed condition, and to 2 interventions - of which Revlite Laser System with hydroquinone skin care regimen is the first listed.
NCT02110134 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02110134 about?
NCT02110134 is a clinical study titled "A Study of the RevLite Laser System for the Treatment of Refractory Mixed Type Melasma". The purpose of this study is to compare a hydroquinone skin care regimen alone to a combination of Revlite Laser treatment with a hydroquinone skin care regimen for the treatment of melasma.
What is the current status of trial NCT02110134?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2013-12. Estimated completion is 2014-05.
What conditions does trial NCT02110134 study?
This clinical trial studies the following conditions: Melasma.
What interventions are being tested in trial NCT02110134?
The interventions under investigation include: Revlite Laser System with hydroquinone skin care regimen (DEVICE), Hydroquinone skin care regimen (OTHER).
Who is sponsoring clinical trial NCT02110134?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02110134 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melasma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02110134's enrollment target sits among peer trials
6 9th of 8 the lowest of 8 other Melasma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Melasma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sylfirm X Radiofrequency Microneedling for the Treatment of Melasma
RECRUITING · NA
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
-
LaseMD System for the Treatment of Melasma
ACTIVE NOT RECRUITING · NA
-
Efficacy and Safety of PiQo4 Device for Treatment of Melasma
COMPLETED · NA
-
Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Participants With Moderate Facial Melasma
COMPLETED · NA
-
Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia